You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 25, 2024

CLINICAL TRIALS PROFILE FOR FLUOCINOLONE ACETONIDE; NEOMYCIN SULFATE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for fluocinolone acetonide; neomycin sulfate

Trial ID Title Status Sponsor Phase Start Date Summary
NCT02168478 ↗ Neo-Synalar Modified 48 Hour Patch Test Completed Noah Rosenberg, MD Phase 4 2014-06-01 A 48 hour patch test performed in healthy volunteers to determine the presensitization (pre-existing allergy) of Neo-Synalar (neomycin sulfate 0.5%(0.35% neomycin base), fluocinolone acetonide 0.025%) Cream . Subjects also receive a positive control (Sodium Lauryl Sulfate) and a negative control (Saline). The primary objective of this study is to determine if any subjects exhibit an allergic reaction which may be indicative of a pre-existing sensitization.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for fluocinolone acetonide; neomycin sulfate

Condition Name

Condition Name for fluocinolone acetonide; neomycin sulfate
Intervention Trials
Allergy 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for fluocinolone acetonide; neomycin sulfate
Intervention Trials
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for fluocinolone acetonide; neomycin sulfate

Trials by Country

Trials by Country for fluocinolone acetonide; neomycin sulfate
Location Trials
United States 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for fluocinolone acetonide; neomycin sulfate
Location Trials
New Jersey 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for fluocinolone acetonide; neomycin sulfate

Clinical Trial Phase

Clinical Trial Phase for fluocinolone acetonide; neomycin sulfate
Clinical Trial Phase Trials
Phase 4 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for fluocinolone acetonide; neomycin sulfate
Clinical Trial Phase Trials
Completed 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for fluocinolone acetonide; neomycin sulfate

Sponsor Name

Sponsor Name for fluocinolone acetonide; neomycin sulfate
Sponsor Trials
Noah Rosenberg, MD 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for fluocinolone acetonide; neomycin sulfate
Sponsor Trials
Industry 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.